Community Health Q2 revenue falls more than expected, hurt by sale of hospitals
Reuters2026/07/22 20:27
Overview
U.S. hospital operator's Q2 revenue fell 9.8% yr/yr, missing analyst expectations
Adjusted EBITDA for Q2 was a slight miss versus consensus
Company used divestiture proceeds to repurchase $599 mln in senior secured notes
Outlook
Company did not provide specific guidance or forecasts for the current or future periods in press release
Result Drivers
DIVESTITURES - Co said lower revenue and Adjusted EBITDA were primarily due to the sale of hospitals and other assets
PAYOR MIX AND SPECIALIST FEES - Co cited an unfavorable change in payor mix and higher medical specialist fees as factors reducing Adjusted EBITDA
SAME-STORE VOLUME GROWTH - Co said same-store admissions and adjusted admissions increased, supporting same-store revenue growth
Company press release: ID:nBw7J87sQa
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q2 Revenue |
Miss |
$2.83 bln |
$2.88 bln (7 Analysts) |
Q2 Adjusted EBITDA |
Slight Miss* |
$330 mln |
$331.12 mln (8 Analysts) |
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 4 "hold" and 3 "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities services peer group is "buy."
Wall Street's median 12-month price target for Community Health Systems Inc is $3.50, about 9% above its July 21 closing price of $3.21
Reuters Recommended Reads
July 22 - Healthcare Services Group Q2 revenue slightly misses estimates
July 20 - Cardinal Health to buy AdaptHealth diabetes unit, Strive Medical for $360 million
July 22 - Generic drug sector seeks policy fixes after Trump tariff threat
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BlueScope: 2027 Returns Target Includes A$1.30/Share Ordinary Dividend
BlueScope: Lifts Distribution Target to At Least 75% of Free Cash Flow
BlueScope: Now Targets Net Debt of Up to A$1.5 Billion
BlueScope: Executed Two Surplus Land Transactions During FY26